These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25487076)

  • 1. Methylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma.
    Zhang YW; Zhang J; Li J; Zhu JF; Yang YL; Zhou LL; Hu ZL; Zhang F
    Leuk Lymphoma; 2015; 56(8):2429-38. PubMed ID: 25487076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of promoter methylation contributes to the expression of functionally impaired PRDM1β isoform in diffuse large B-cell lymphoma.
    Zhang YW; Xie HQ; Chen Y; Jiao B; Shen ZX; Chen SJ; Zhao WL
    Int J Hematol; 2010 Oct; 92(3):439-44. PubMed ID: 20859709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells.
    Romero-García R; Gómez-Jaramillo L; Mateos RM; Jiménez-Gómez G; Pedreño-Horrillo N; Foncubierta E; Rodríguez-Gutiérrez JF; Garzón S; Mora-López F; Rodríguez C; Valor LM; Campos-Caro A
    Sci Rep; 2020 Sep; 10(1):15899. PubMed ID: 32985591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potential mechanism and prognostic value of promoter methylation of PRDM1 gene in diffuse large B cell lymphoma].
    Zhang XY; Ma ZP; Cui WL; Chen R; Glinaer A; Miao N; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):831-837. PubMed ID: 28056297
    [No Abstract]   [Full Text] [Related]  

  • 5. Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.
    Nie K; Zhang T; Allawi H; Gomez M; Liu Y; Chadburn A; Wang YL; Knowles DM; Tam W
    Am J Pathol; 2010 Sep; 177(3):1470-9. PubMed ID: 20651244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
    Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247
    [No Abstract]   [Full Text] [Related]  

  • 7. Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.
    Rinaldi A; Mensah AA; Kwee I; Forconi F; Orlandi EM; Lucioni M; Gattei V; Marasca R; Berger F; Cogliatti S; Cavalli F; Zucca E; Gaidano G; Rossi D; Bertoni F
    Br J Haematol; 2013 Oct; 163(2):194-204. PubMed ID: 23961875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of expression and promoter methylation of LITAF gene in B-cell lymphoma].
    Wang J; Shi Y; Wang L; Ren G; Bai Y; Shi H; Zhang X; Jiang X; Zhou R
    Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):516-21. PubMed ID: 25346120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma.
    Ferraresso S; Aricò A; Sanavia T; Da Ros S; Milan M; Cascione L; Comazzi S; Martini V; Giantin M; Di Camillo B; Mazzariol S; Giannuzzi D; Marconato L; Aresu L
    Sci Rep; 2017 Sep; 7(1):11591. PubMed ID: 28912427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations.
    Wang XM; Greiner TC; Bibikova M; Pike BL; Siegmund KD; Sinha UK; Müschen M; Jaeger EB; Weisenburger DD; Chan WC; Shibata D; Fan JB; Hacia JG
    J Cell Biochem; 2010 Mar; 109(4):818-27. PubMed ID: 20069569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
    J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.
    Xia Y; Xu-Monette ZY; Tzankov A; Li X; Manyam GC; Murty V; Bhagat G; Zhang S; Pasqualucci L; Visco C; Dybkaer K; Chiu A; Orazi A; Zu Y; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Westin J; Fowler N; Miranda RN; Ok CY; Li Y; Li J; Medeiros LJ; Young KH
    Leukemia; 2017 Mar; 31(3):625-636. PubMed ID: 27568520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation.
    Zhang Z; Liang L; Li D; Nong L; Liu J; Qu L; Zheng Y; Zhang B; Li T
    Hematol Oncol; 2017 Dec; 35(4):645-654. PubMed ID: 27704586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalent hyper-methylation of the CDH13 gene promoter in malignant B cell lymphomas.
    Ogama Y; Ouchida M; Yoshino T; Ito S; Takimoto H; Shiote Y; Ishimaru F; Harada M; Tanimoto M; Shimizu K
    Int J Oncol; 2004 Sep; 25(3):685-91. PubMed ID: 15289870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status.
    Pike BL; Greiner TC; Wang X; Weisenburger DD; Hsu YH; Renaud G; Wolfsberg TG; Kim M; Weisenberger DJ; Siegmund KD; Ye W; Groshen S; Mehrian-Shai R; Delabie J; Chan WC; Laird PW; Hacia JG
    Leukemia; 2008 May; 22(5):1035-43. PubMed ID: 18288132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor.
    Zhao WL; Liu YY; Zhang QL; Wang L; Leboeuf C; Zhang YW; Ma J; Garcia JF; Song YP; Li JM; Shen ZX; Chen Z; Janin A; Chen SJ
    Blood; 2008 Apr; 111(7):3867-71. PubMed ID: 18235046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible Role of GADD45γ Methylation in Diffuse Large B-Cell Lymphoma: Does It Affect the Progression and Tissue Involvement?
    Barış İC; Caner V; Şen Türk N; Sarı İ; Hacıoğlu S; Doğu MH; Çetin O; Tepeli E; Can Ö; Bağcı G; Keskin A
    Turk J Haematol; 2015 Dec; 32(4):295-303. PubMed ID: 25912017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL.
    Wang W; Wang J; Li Z; Zhu M; Zhang Z; Wang Y; Jing H
    Oncol Rep; 2016 Jan; 35(1):139-46. PubMed ID: 26498513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.
    Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A
    Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.